HNB
IRMD icon

Huntington National Bank’s iRadimed IRMD Stock Holding History

Huntington National Bank’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178K Sell
1,846
-154
-8% -$15.4K ﹤0.01% 895
2025
Q4 		$195K Sell
2,000
-170
-8% -$14.6K ﹤0.01% 769
2025
Q3 		$154K Buy
2,170
+64
+3% +$4.26K ﹤0.01% 844
2025
Q2 		$126K Buy
2,106
+111
+6% +$6.08K ﹤0.01% 879
2025
Q1 		$105K Buy
1,995
+2
+0.1% +$112 ﹤0.01% 904
2024
Q4 		$110K Buy
1,993
+506
+34% +$26.6K ﹤0.01% 910
2024
Q3 		$74.8K Buy
1,487
+504
+51% +$23.3K ﹤0.01% 1019
2024
Q2 		$43.2K Buy
983
+123
+14% +$5.23K ﹤0.01% 1175
2024
Q1 		$37.8K Buy
860
+35
+4% +$1.55K ﹤0.01% 1223
2023
Q4 		$39.2K Buy
825
+347
+73% +$14.6K ﹤0.01% 1169
2023
Q3 		$21.2K Buy
478
+199
+71% +$9.25K ﹤0.01% 1324
2023
Q2 		$13.3K Buy
+279
New +$12.6K ﹤0.01% 1486
2016
Q1 		– Sell
-426
Closed -$12K – 1772
2015
Q4 		$12K Buy
+426
New +$12K ﹤0.01% 1335

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Huntington National Bank's IRMD Position: Q1 2026 in Review

Huntington National Bank reduced its iRadimed (IRMD) stake by 7.7% in Q1 2026, selling an estimated $15.4K and leaving 1,846 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Huntington National Bank first reported a position in IRMD in Q4 2015 and has held it in 13 quarters since. The position peaked at $195K in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Huntington National Bank held 1,846 shares of iRadimed worth $178K as of Q1 2026.
  • Huntington National Bank sold 154 iRadimed shares in Q1 2026, an estimated $15.4K.
  • iRadimed made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #895 holding.
  • Huntington National Bank first reported a position in iRadimed in Q4 2015 and has held it in 13 quarters since.
  • Huntington National Bank's iRadimed position peaked at $195K in Q4 2025.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.